Franklin Resources’s Sutro Biopharma STRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-9,180
Closed -$169K 3065
2024
Q4
$169K Sell
9,180
-144
-2% -$4.4K ﹤0.01% 2680
2024
Q3
$357K Sell
9,324
-218
-2% -$8.54K ﹤0.01% 2430
2024
Q2
$280K Buy
+9,542
New +$377K ﹤0.01% 2453
2024
Q1
Sell
-276,264
Closed -$11.9M 2960
2023
Q4
$11.9M Sell
276,264
-7,172
-3% -$228K 0.01% 892
2023
Q3
$9.84M Sell
283,436
-3,318
-1% -$145K 0.01% 916
2023
Q2
$13.3M Buy
286,754
+2,967
+1% +$148K 0.01% 863
2023
Q1
$13.1M Sell
283,787
-27
-0% -$1.71K 0.01% 869
2022
Q4
$22.9M Sell
283,814
-95,064
-25% -$6.61M 0.01% 736
2022
Q3
$21M Buy
378,878
+1,488
+0.4% +$88.1K 0.01% 755
2022
Q2
$19.7M Buy
377,390
+2,599
+0.7% +$145K 0.01% 798
2022
Q1
$30.8M Buy
374,791
+47,996
+15% +$4.57M 0.01% 744
2021
Q4
$48.6M Buy
326,795
+31,510
+11% +$5.65M 0.02% 645
2021
Q3
$55.8M Buy
295,285
+10,437
+4% +$1.98M 0.02% 615
2021
Q2
$53M Buy
284,848
+20,168
+8% +$3.95M 0.02% 632
2021
Q1
$60.2M Buy
264,680
+41,988
+19% +$9.96M 0.02% 562
2020
Q4
$48.3M Buy
+222,692
New +$36.9M 0.02% 601

Other funds holding STRO

Franklin Resources's STRO Position: Q1 2025 in Review

Franklin Resources sold out of Sutro Biopharma (STRO) in Q1 2025, closing a stake of 9,180 shares — an estimated $169K sold.

Franklin Resources first reported a position in STRO in Q4 2020 and held it in 16 quarters. The position peaked at $60.2M in Q1 2021. 112 funds tracked by Wall St. Rank hold STRO as of Q1 2025.

  • Franklin Resources reported no remaining Sutro Biopharma position as of Q1 2025 after selling out during the quarter.
  • Franklin Resources sold 9,180 Sutro Biopharma shares in Q1 2025, an estimated $169K.
  • Franklin Resources first reported a position in Sutro Biopharma in Q4 2020 and held it in 16 quarters.
  • Franklin Resources's Sutro Biopharma position peaked at $60.2M in Q1 2021.
  • 112 funds tracked by Wall St. Rank held Sutro Biopharma as of Q1 2025.

Based on Franklin Resources's 13F filing for Q1 2025, filed 13 May 2025.